📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Lilly

1.1 - Company Overview

Lilly Logo

Lilly

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of medicines for diabetes, cancer, immunology, and other major health areas, including insulin products with affordability initiatives ($35 or less/month); Efsitora for type 2 diabetes via autoinjector; EBGLYSS for moderate-to-severe atopic dermatitis; Jaypirca for relapsed/refractory MCL and CLL/SLL; Zepbound (tirzepatide) for obesity; Verzenio for HR+, HER2- early breast cancer.

Products and services

  • Zepbound (tirzepatide): A medication for obesity in single-dose vials, delivering a cost-effective option compared to other incretin medicines for patients
  • Efsitora: A medication used in the treatment of type 2 diabetes, administered via autoinjector, helping patients achieve A1C reduction
  • EBGLYSS: A biologic treatment for moderate-to-severe atopic dermatitis, providing skin clearance and itch relief for patients

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Lilly

Confo Therapeutics Logo

Confo Therapeutics

HQ: Belgium Website
  • Description: Provider of GPCR-focused drug discovery solutions leveraging proprietary Confo® Technology and conformationally selective VHH ConfoBodies® to stabilize GPCRs in active, disease-relevant states. Offerings include ConfoScreen®, ConfoSensor®, and ConfoStructure™ for screening, biosensing, and structure-based design, and MegaBody™ for high-resolution cryo-EM, enabling novel medicine discovery and internal programs addressing unmet medical need.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Confo Therapeutics company profile →
GSK Logo

GSK

HQ: United Kingdom Website
  • Description: Provider of pharmaceutical medicines, vaccines, and consumer healthcare products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GSK company profile →
LP Pharmaceuticals Logo

LP Pharmaceuticals

HQ: China Website
  • Description: Provider of pharmaceuticals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LP Pharmaceuticals company profile →
Stada Logo

Stada

HQ: Germany Website
  • Description: Provider of pharmaceuticals and non-prescription consumer health products, operating on three pillars: OTC consumer healthcare, generics, and specialty pharmaceuticals. Sells products in over 120 countries, including acetaminophen, lactulose, Grippostad-C, Vitaprost, Cardiomagnyl, Xefocam Rapid, Aqualor, Edarbi, and Levomekol.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Stada company profile →
Sagimet Biosciences Logo

Sagimet Biosciences

HQ: United States Website
  • Description: Provider of novel therapeutics targeting FASN, including Denifanstat, an oral, once-daily selective FASN inhibitor in development for MASH, acne, and certain cancers, and TVB-3567, a pipeline FASN inhibitor planned for U.S. clinical development for acne.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sagimet Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Lilly

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Lilly

2.2 - Growth funds investing in similar companies to Lilly

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Lilly

4.2 - Public trading comparable groups for Lilly

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Lilly

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Lilly

What does Lilly do?

Lilly is a provider of medicines for diabetes, cancer, immunology, and other major health areas, including insulin products with affordability initiatives ($35 or less/month); Efsitora for type 2 diabetes via autoinjector; EBGLYSS for moderate-to-severe atopic dermatitis; Jaypirca for relapsed/refractory MCL and CLL/SLL; Zepbound (tirzepatide) for obesity; Verzenio for HR+, HER2- early breast cancer.

Who are Lilly's competitors?

Lilly's competitors and similar companies include Confo Therapeutics, GSK, LP Pharmaceuticals, Stada, and Sagimet Biosciences.

Where is Lilly headquartered?

Lilly is headquartered in United States.

How many employees does Lilly have?

Lilly has 1,000 employees 🔒.

When was Lilly founded?

Lilly was founded in 2010 🔒.

What sector and industry vertical is Lilly in?

Lilly is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Lilly

Who are the top strategic acquirers in Lilly's sector and industry

Top strategic M&A buyers and acquirers in Lilly's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Lilly?

Top strategic M&A buyers groups and sectors for Lilly include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Lilly's sector and industry vertical

Which are the top PE firms investing in Lilly's sector and industry vertical?

Top PE firms investing in Lilly's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Lilly's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Lilly's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Lilly's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Lilly include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Lilly's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Lilly?

The key public trading comparables and valuation benchmarks for Lilly include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Lilly for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Lilly with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Lilly's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Lilly with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Lilly's' sector and industry vertical?

Access recent funding rounds and capital raises in Lilly's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Lilly

Launch login modal Launch register modal